Search - tctmd.com

Displaying 1 - 20 of 179

Sort: Relevancy | Date

News Conference News ACC 2026

Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering

Michael O'Riordan

April 01, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2026

Caitlin E. Cox

April 01, 2026

News Conference News ACC 2026

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

Michael O'Riordan

March 29, 2026

News Conference News ACC 2026

Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE

Yael L. Maxwell

March 28, 2026

News Opinion CV Team Dispatch

March 2026 Dispatch for the CV Team

L.A. McKeown

March 26, 2026

News Daily News

Genomics, Lipids, Inflammation at Midlife Predict Future CAD

Caitlin E. Cox

March 25, 2026

News Daily News

Premature Menopause Increases Lifetime Heart Disease Risk Regardless of Race

L.A. McKeown

March 23, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Daily News

Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk

Yael L. Maxwell

March 19, 2026

News Daily News

Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines

Michael O'Riordan

March 13, 2026

News Daily News

Adult Survivors of Childhood Cancer May Do Well With Simple Strategy for CV Risk

Caitlin E. Cox

February 13, 2026

News Daily News

Year in Review: Top Prevention Stories of 2025

Michael O'Riordan

December 24, 2025

News Conference News AHA 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

Todd Neale

November 08, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2025

Michael O'Riordan

September 30, 2025

News Daily News

European Experts Provide Advice on Managing CV Effects of COVID-19

Todd Neale

September 19, 2025

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

News Daily News

Half of Patients Stop Semaglutide for Weight Loss by 1 Year

Todd Neale

September 18, 2025

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

News Conference News ESC 2025

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

Caitlin E. Cox

August 29, 2025

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

Advertisement

Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering

TCTMD’s Top 10 Most Popular Stories for March 2026

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE

March 2026 Dispatch for the CV Team

Genomics, Lipids, Inflammation at Midlife Predict Future CAD

Premature Menopause Increases Lifetime Heart Disease Risk Regardless of Race

What’s Going to Be Hot at ACC 2026

Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk

Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines

Adult Survivors of Childhood Cancer May Do Well With Simple Strategy for CV Risk

Year in Review: Top Prevention Stories of 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

TCTMD’s Top 10 Most Popular Stories for September 2025

European Experts Provide Advice on Managing CV Effects of COVID-19

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Half of Patients Stop Semaglutide for Weight Loss by 1 Year

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

What’s Going to Be Hot at ESC Congress 2025?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content